This unique and comprehensive collection investigates the
challenges posed to intellectual property by recent paradigm shifts
in biology. It explores the legal ramifications of emerging
technologies, such as genomics, synthetic biology, stem cell
research, nanotechnology, and biodiscovery. Extensive contributions
examine recent controversial court decisions in patent law - such
as Bilski v. Kappos, and the litigation over Myriad's patents in
respect of BRCA1 and BRCA2 - while other papers explore sui generis
fields, such as access to genetic resources, plant breeders'
rights, and traditional knowledge. The collection considers the
potential and the risks of the new biology for global challenges -
such as access to health-care, the protection of the environment
and biodiversity, climate change, and food security. It also
considers Big Science projects - such as biobanks, the 1000 Genomes
Project, and the Doomsday Vault. The inter-disciplinary research
brings together the work of scholars from Australia, Canada,
Europe, the UK, and the US and involves not only legal analysis of
case law and policy developments, but also historical, comparative,
sociological, and ethical methodologies. Intellectual Property and
Emerging Technologies will appeal to policy makers, legal
practitioners, business managers, inventors, scientists, and
researchers. Contributors include: A. Agovic, A. Bostanci, J.
Calvert, G. Dutfield, D.M. Gitter, R. Gold, F. Hemmings, E.
Hemmungs Wirten, S. Holcombe, T. Janke, P.-B. Joly, Y. Joly, A.
McLennan, D. Nicol, M. Rimmer, J.D. Sarnoff
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!